Pfizer is giving away a free equine weigh tape with every purchase of Equest & Equest Pramox (while stocks last), to help encourage accurate treatment against encysted small redworms this season.
According to the company, Equest & Equest Pramox are the only wormers in the UK that treat encysted small redworm in a single dose. Using a weigh tape to work out their horse's weight will help your clients avoid under dosing, which increases the risk of resistance development.
Pfizer says small redworms are the most common worms found in horses today. They can pose a very serious health risk to horses and it's important for owners to make sure that they are treated properly during the autumn or early winter.
Small redworms can grow up to 2.5cm in length and are thin and reddish in colour. Small redworm eggs are passed in the faeces and then hatch on pasture and continue to develop into more advanced larval stages before being ingested by the horse as it grazes. The larvae burrow deeply into the wall of the gut where they encyst and may account for up to 90% of the redworm burden in the horse1. Encysted small redworm will not show up in a Faecal Worm Egg Count - even if the horse has shown a negative or low count it could still be harbouring several million encysted small redworms2.
Encysted small redworms can remain dormant inside a horse for up to two years, but they usually 'wake-up' in late winter or early spring, developing and emerging from the gut wall all at the same time. In severe infestations mass emergence can lead to a disease syndrome known as 'larval cyathostominosis', causing diarrhoea and colic with up to a 50% mortality rate3. Young horses of less than six years of age can often be at higher risk of the disease3 but small redworm can cause life-threatening illness at any time of year and in any age of horse.
Ben Gaskell, Pfizer's veterinary adviser said: "Treating encysted small redworms successfully in the late autumn or early winter is important to avoid the risk of larval cyathostominosis. It's important to advise your customers to choose a product that is licensed to treat the worms they are targeting and that they give the correct dose, by weighing their horse beforehand, as this will help preserve the efficacy of the drug used."
Pfizer's Does your wormer measure up campaign is backed with point of sale materials and a media campaign. To receive a free weigh tape, valued at £7 your clients need to buy a tube of Equest or Equest Pramox, fill in an application form and send Pfizer the batch and expiry flap from the pack. Pfizer will then send them a FREE Weigh Tape while stocks last.
For further information contact your Pfizer Account Manager.
References
1. Bairden K. et al (2001) Veterinary Record 148, 138-1412. Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑2423. McWilliam H. et al (2010) International Journal for Parasitology 40, 265-275
Genitrix has announced that HY-50 Vet®, a sodium hyaluronate treatment for equine joints, has now been authorised for intravenous (IV) use.
Available until now for intra-articular (IA) use only, the company says HY-50 delivers the highest concentration of sodium hyaluronate on the market for the treatment of non-infectious joint inflammation and the enhancement of joint function.
Genitrix also says that, as IV application requires less specialist preparation than IA, HY-50 is now a practical solution for mixed practices with a smaller equine case load. Injected intravenously, the product will also benefit horses with multiple joint injuries.
HY-50 is presented in a 3 ml pre-loaded syringe, delivering 50 mg of sodium hyaluronate. It costs £55.50.
Rob Watkins, Marketing Director of Genitrix, said: "The efficacy of sodium hyaluronate is well established and we're delighted to be able to offer the IV route of administration. We know it will meet a real need in the market for a lameness treatment which is proven and simple to administer."
"Perhaps most importantly, in these financially difficult times, the high concentration of the product makes it a cost-effective approach compared with competitive products. We believe it will offer an affordable treatment option for owners who are anxious to treat their horses but may be discouraged by the high cost of many treatments."
For further information, see http://www.genitrix.co.uk/ or ring 01403 786345.
Pfizer Animal Health has launched a dedicated Equine Business Unit to provide a higher level of service and a comprehensive range of products to equine vets across the UK.
Created following the merger with Fort Dodge, the Pfizer Equine Business Unit is headed by Ben Lacey MA Vet MB MRCVS, who has previously held both technical and sales roles at Pfizer. Ben and his team have a brief to offer a breadth of product, support and flexibility not previously available to equine vets.
The product range offered by the Pfizer Equine Business Unit includes the Equest range of parasiticides; the Duvaxyn vaccines for Equine Herpes Virus, West Nile Virus and Rotavirus and products such as Equimidine and Torbugesic. Also offered are existing Pfizer brands such as the Equip vaccine range, the antibiotic Excenel Sterile Powder, the NSAID Rimadyl for Horses and Depo-MedroneV.
Five experienced account managers with a strong track record in the equine sector have been appointed by Pfizer to build relationships with equine vet practices on a regional basis. They are:
South East England Mark BakerWest Midlands, Cheshire, Wales Laurie MayEast Anglia, East Midlands Penny McCannSouth West, South Wales Anna CunninghamThe North, Scotland Alexandra Cox
Ben Lacey said: "Building our new team and combining the highly regarded products offered previously by both Fort Dodge and Pfizer has proved a stimulating process. We've also worked closely with many of our existing practice customers to look at how we can develop the service we provide to them.
"We're now able to offer a product range which I believe is unrivalled in the market and a highly committed team of equine professionals, who share a vision and passion for equine health. We're looking forward to building our business with both existing and new customers in the months ahead."
The Government's updated Exotic Animal Disease Contingency Plan was laid in Parliament today.
The revised plan is produced by Animal Health for Defra, and includes changes which have been subject to formal public consultation. This includes a framework response plan for dealing with exotic animal diseases and plans for responding to specific diseases including Foot and Mouth Disease, Avian Influenza and Newcastle Disease.
The changes to the plan reflect lessons identified from the incidents handled during 2008 and address recommendations made in Sir Iain Anderson's review of the 2007 outbreak of Foot and Mouth Disease and feedback from the public consultation.
Jane Kennedy, Minister for Farming and the Environment said: "An animal disease outbreak can be devastating for those concerned. Defra remains totally committed to ensuring we learn lessons from our experience of outbreaks, so that we can make sure we respond effectively in future".
The Contingency Plan is subject to ongoing revision based on the latest scientific advice, developments in policy, comments from stakeholders and operational partners together with the lessons identified from disease outbreaks. It can be accessed here:www.defra.gov.uk/animalh/diseases/control/contingency/index.htm
The webinar will be presented by Dr Abigail McGlennon from the Equine Infectious Disease Surveillance (EIDS) team at the University of Cambridge who will present data from the Surveillance of Equine Strangles (SES) network to provide a detailed overview of strangles diagnoses across the UK.
Abigail will explore recent trends in outbreak reports, the genetic makeup of recent circulating strains and transmission links between UK outbreaks.
By linking research from her own PhD work on S. equi genomics and transmission with preventative strategies, Abigail show how to suggest and implement evidence-based prevention measures to clients.
The webinar will also offer advice on ‘the ates’ preventative measures – vaccinate, isolate, investigate and communicate – and will include information on when horse owners should be vaccinating with Strangvac and an outbreak management vaccination plan using the traffic light ‘green, amber and red’ system.
https://go.dechra.co.uk/preventative_strategies_for_strangles
A graduate of the University of Córdoba, Spain, Sonya trained and worked across Europe and the United States, including at the Animal Health Trust, The Royal Veterinary College, Colorado State University and Nottingham University.
Her clinical interests span neurology, ophthalmology, muscular disorders, and infectious diseases, and she is widely recognised for her contributions to equine research.
She continues to contribute to ongoing studies in exercise biomarkers, toxicology, and infectious disease management, and regularly presents her findings at national and international veterinary conferences.
Andrew Jones, Clinical Director and Specialist Surgeon at CVS Endell Equine Hospital said: “Internal medicine specialists such as Dr. Gonzalez-Medina, with her comprehensive expertise spanning multiple body systems, will be instrumental in enhancing Endell’s existing services."
The new service will cover a broad spectrum of equine medical conditions, including:
Andrew added: “Our area has lacked this type of service for patients in the past, meaning horses can now access advanced internal medicine care without traveling great distances.”
The Equine Internal Medicine Service is now accepting referrals and direct cases.
https://www.endellequinehospital.co.uk.
The company now expects the vaccine will not be available until June 2025.
The company apologised for the disruption and inconvenience and says it will provide more information as soon as it becomes available.
For further information contact your Zoetis Account Manager or call Head Office on 0345 300 8034.
A new diagnostic blood test has been developed to combat the virulent horse disease Strangles.
The breakthrough has come after four years of research by scientists at the Animal Health Trust in Newmarket.
The blood test identifies horses that have recently been exposed to Strangles, enabling it to be nipped in the bud.
Oliver Wilson, campaign director at The British Horse Society, said: "It is fantastic news. This big breakthrough is a real boon to horse owners and I believe will lead to a significant drop in Strangles outbreaks. But there is still much to be done.
"The AHT's work to develop and test a fully effective vaccine against Strangles is ongoing. To support it we need to raise another £120,000 by the end of this year to reach the campaign target of £250,000."
For more information about the Strangles campaign, visit http://www.strangles.org/
Britain's leading equestrian organisations are conducting a survey to find out more about the welfare standards in livery yards. Livery yards are very popular in the UK for those people who are unable to keep their horses and ponies at home. However, there is no record of how many horses are currently at livery or indeed the number of operating yards and the welfare standards under which they operate. Representatives from the British Equine Veterinary Association (BEVA), World Horse Welfare, The British Horse Society, RSPCA, Association of British Riding Schools, South Essex Insurance Brokers (who currently insure a total of 8,562 DIY and livery stables), and for local government LACORS and CIEH, set up a working party to carry out some research into UK livery yards to become better informed about standards. The group took the view that asking vets and the public about their local livery yard would help to obtain information about the number of yards and get a general picture of the range and standard of accommodation and services that livery yards offer. Veterinary surgeons, horse owners, grooms, yard owners, farriers and other equine professionals are invited to complete the online survey at http://www.liveryyardsurvey.co.uk/. Please complete a survey for each livery yard about which you have first hand knowledge. Your answers will remain confidential, and the results will be reviewed in September 2008 to establish what further action, if any, is necessary.
The webinar is being presented by Cassie Woods (RVN Cons) CertNCS, Equine Nurse and Partner at Lower House Equine Clinic in Shropshire.
Cassie has a degree in bio-veterinary science and many years experience working in equine and small animal practice.
She regularly lectures for BVNA and BEVA. She is a member of the BEVA equine nurse committee and works closely with the BEVA Trust.
Cassie will share insights and practical strategies to strengthen biosecurity for both clinic and ambulatory teams, and will offer advice and guidance for helping clients to improve their own biosecurity measures.
Horiba's Veterinary specialists will also be available to answer veterinary diagnostics-related questions and share information about the range of pathogen tests the company offers.
https://horiba.link/register-143bbc
Photo: www.depositphotos.com
The farriery stream will run all day on Saturday 14 September, with content curated by Dr Simon Curtis who is internationally renowned in the hoof-care world for his remedial farriery textbooks and lectures.
Simon said: “Any historical, perceived divide between science of veterinary medicine and the craft of farriery is no longer in existence.
"The overlap is vast which means it is more essential than ever that vets, nurses and farriers understand each other’s roles in order to maximise their patient outcomes.”
“Farriery isn’t sexy, but it beats everything else for improving soundness.
"It is impossible to maintain or regain soundness without farriery being considered as an integral part of the process.
“The impact good farriery can have on a horse’s ability to tolerate conformational, work-related or other causes of lameness associated pathology is all too often overlooked by all parties, and this should no longer be the case.
"Vets and farriers must work as a team to avoid injury and facilitate recovery wherever possible.”
The sessions will cover things like the importance of trimming, the biomechanical effects of horseshoes, why heels collapse, chronic club foot, digital support and toe-trimming.
The farriery stream is part of 90+ hours of live and on-demand CPD on offer at Congress, with interactive discussions, debates and workshops, and an expanded stream for vet nurses.
https://www.bevacongress.org/programme
BEVA members prices for Congress for all three days are £699 for vets (with concessionary prices available for those in their first three years of graduation or earning less than £25,000), £273 for nurse members for all three days and £300 for farriers and other allied professionals for all three days or £110 for one day.
Practice passes are also available.
Boehringer Ingelheim Vetmedica has released data which shows that one third of laminitic middle aged horses (between the ages of 10 and 15 years) test positive for PPID (Cushing's)1.
Over 3,100 horses were tested for Cushings as part of the company's 'Talk about Laminitis' campaign during the spring.
Liz Barrett, equine sales and marketing manager at Boehringer Ingelheim Vetmedica said: "Although the common perception is that PPID is a disease of only older horses and ponies, the ageing process is progressive and this data from over 330 participating veterinary practices1 indicates that horses and ponies in the 10 to 15 age bracket are also frequently affected."
The company is urging veterinary surgeons to test laminitic or foot-sore horses for PPID this autumn, as this is when there is a greater difference between horses with PPID and those free of the disease2, 3. In support of this, Boehringer will be re-launching its disease awareness initiative 'Talk About Laminitis', with free ACTH blood tests* during September, October and November. To participate in the scheme, veterinary surgeons can download free ACTH blood test vouchers from http://www.talkaboutlaminitis.co.uk/.
Dr Catherine McGowan BVSc DipVetClinStud MACVSc PhD DEIM DipECEIM FHEA MRCVS from the University of Liverpool, said: "It is very important to test horses for PPID the first time they present with laminitis because what we want to avoid is recurrence of that laminitis. If it does reoccur, the damage will be worse and the chances of that horse having a successful long-term recovery will be diminished."
For further information on 'Talk About Laminitis', PPID or Prascend, visit www.talkaboutlaminitis.co.uk, contact your Boehringer territory manager or call 01344 746959.
Pfizer Animal Health is reminding horse owners of the importance of treating encysted small redworm larvae this autumn.
According to the company, these hidden, dormant parasites can account for up to 90% of the redworm burden in a horse (1). Furthermore, encysted small redworm larvae won't show up in a faecal egg count (FEC). Even if a horse has shown a negative or low count it could still be harbouring several million harmful larvae, hidden within the gut wall (2)
Encysted small redworm are a potential time bomb, with the ability to survive inside a horse for up to two years. They usually 'wake-up' in the late winter or early spring, developing and emerging from the gut wall all at the same time. Such a sudden mass emergence can cause a disease syndrome known as 'larval cyathostominosis', causing diarrhoea and colic with up to a 50% mortality rate (2). Treating encysted small redworm successfully in the late autumn or early winter is vitally important in order to prevent this serious risk.
Pfizer says that Moxidectin, the key ingredient of EQUEST, is recognised as the only single dose treatment for encysted small redworm. It has been shown to kill the larvae in-situ, without resulting in severe inflammation of the gut wall that other multi-dose treatments may cause (3). In addition, Moxidectin is licensed for persistent activity against small redworm over two weeks, killing larvae ingested as the horse grazes for up to two weeks after treatment.
Ben Gaskell, Pfizer's veterinary advisor said: "A responsible and sustainable worming programme involves good pasture management, regular diagnostic tests and targeted worming, carefully planned using specialist advice. However, it is also vital to remember the danger of encysted small redworm. Even if a horse's FEC is clear, there could still be a significant encysted small redworm burden that must be treated properly every year in late autumn / early winter."
1) Bairden K. et al (2001) Veterinary Record 148, 138-141 2) Dowdall S.M.J. et al (2002) Veterinary Parasitology 106, 225‑242 3) Steinbach T. et al (2006) Veterinary Parasitology 139, 115‑131
Defra Minister David Heath has announced the latest bute (phenylbutazone) test results. The presence of bute has been confirmed in 8 samples out of 206 tests.
Chief Medical Officer Professor Dame Sally Davies has stated that horsemeat containing phenylbutazone presents a very low risk to human health.
Responding to these latest developments the British Veterinary Association (BVA) and British Equine Veterinary Association (BEVA) have issued the following statement:
"The presence of phenylbutazone (or bute) in horses intended for the food chain will be of concern to consumers who rightly expect the UK food chain to be robust. We are grateful to the Chief Medical Officer for clarifying the very low level of risk that this presents to human health and we will work with the FSA and Defra in any way we can to assist their investigations into these incidents.
"The ability to treat horses with bute is very important for equine welfare. Bute provides affordable, long-term pain relief for horses and is unique in this respect.
"The UK Horse Passport Regulations are designed to facilitate the ongoing medical treatment of horses not intended for the human food chain, whilst ensuring that these animals do not enter the food chain.
"We fully support the concept of the Horse Passport Regulations but have argued for some time that there are problems with the system in terms of the number of Passport Issuing Authorities and the vulnerability of the system to fraud. We are very keen to continue our dialogue with Defra and others to find ways to make the system more robust.
"Our members are aware of the strict rules regarding the regulation of medicines (including bute) and the use of horse passports, and in recent years we have provided clear guidance on the regulations to help both vets and their clients. These incidents will hopefully reinforce these messages amongst horse owners and all of us involved in equine healthcare."
Guidance notes are available via the BEVA website Medicines Page (http://www.beva.org.uk/useful-info/Vets/Guidance/Medicines)
Scientists from the Animal Health Trust, the Wellcome Trust Sanger Institute and the University of St. Andrews have pinpointed the genes which allow the bacteria responsible for strangles to thrive, thereby paving the way for the development of a vaccine.
In the study, which the researchers say was the largest of its kind, 224 samples of Streptococcus equi (S. equi) were procured from horses around the globe to try and find a common bacterial ancestor from which modern strains would have developed. Despite the disease first being described in 1251, the researchers were surprised at the genetic similarity of the samples and identified a total population replacement at the 19th or early 20th century. This corresponds to a period when horses from around the world were brought together in global conflicts including World War I, where an estimated eight million horses died on the battlefield.
Dr Simon Harris from the Wellcome Trust Sanger Institute said: “The mobilisation and mixing of horses in conflicts such as WWI provided perfect conditions for S. equi to thrive. This combined with high mortality rates among the horses and their replacement with young susceptible horses could explain what we see around the world today".
While loss of diversity could be considered detrimental to bacterial populations, S. equi still infects more than 20,000 horses in the UK alone each year. Its success, researchers believe, is due to its ability to persist in some horses for years after they have recovered from strangles, where the bug can evolve to evade the horse’s immune system.
Dr Andrew Waller, Head of Bacteriology at the Animal Health Trust said: “The data we have gathered in this study has enabled us to pinpoint the genes that help the bacteria to persist, spread and thrive in the horse population. This research provides an unprecedented opportunity to reduce the impact of and prevent strangles in future generations of horses.”
The AHT says that the ability of S. equi to adapt to living in a persistent state within its host and still infect new horses mirrors the situation with HIV and the bacteria that causes tuberculosis in humans. Dr Matthew Holden from the Wellcome Trust Sanger Institute and the University of St Andrews said: “Unravelling the complex population dynamics of S. equi sheds new light on the balancing act between acute and persistent infection that is going on in many pathogens. Not only does this collection of whole-genome sequences for S. equi offer hope for an effective strangles vaccine, it also provides us with a useful model for understanding persistent infection in humans.”
The Department for Environment, Food and Rural Affairs (Defra) and the Food Standards Agency (FSA) are reminding veterinary surgeons of their legal responsibilities under the Horse Passport Regulations 2009.
The move follows a small number of horses testing positively for the presence of phenylbutazone, which, if consumed, can be harmful to human health.
Defra and the FSA have asked for the assistance of the profession in ensuring that treatment with phenylbutazone is properly recorded in Horse Passports and have said that they are working together to understand the cause of the positive tests, and what longer term measures can be put in place to stop this happening.
In the interim, all horses slaughtered for human consumption will be sampled for the presence of phenylbutazone, with immediate effect.
The letter from Defra and the FSA can be downloaded from the RCVS website.
The full advice can be read in a Veterinary Medicines Directorate/Defra leaflet, which can be found online at http://www.vmd.defra.gov.uk/pdf/leaflet_horses.pdf.
Mark Bowen, Chair of the British Equine Veterinary Association's Health and Medicines Committee, said: "The number of horses entering the human food chain from the UK has doubled since 2009 and is no longer an insignificant minority of horses. All vets should be checking horse passports and only dispensing sensible quantities of this drug, and its prodrug suxibuzone."
Meanwhile, a form is available from the British Equine Veterinary Association website for veterinary surgeons to use if the horse passport is not available, but emergency treatment is required: http://www.beva.org.uk/_uploads/documents/emergency-treatment-form-no-passport-2011.pdf
Horses suffering from neurological conditions similar to those that affect humans could be helped by a breakthrough from stem cell scientists, according to a study published in the journal Stem Cells and Development.
Researchers at the University of Edinburgh's Roslin Institute took skin cells from a young horse and turned them into stem cells using a technique that was originally developed for human cells. The reprogrammed cells are pluripotent, which means they can be induced to become any type of cell in the body. The team used them to create nerve cells in the laboratory and tested whether they were functional by showing that they could transmit nerve signals in a test tube.
The university says horse stem cells have been produced in the laboratory before but this is the first time that scientists have created working cells of a specific type from them. The advance may pave the way for cell therapies that target conditions similar to motor neurone disease.
In addition, the research could also benefit horses affected by grass sickness, a neurological condition that affects around 600 horses a year in the UK. Little is known about the disease, which causes nerve damage throughout the body. It is untreatable and animals with the most severe form usually die or have to be put down.
Dr Xavier Donadeu from the Roslin Institute, an author of the study, said: "Stem cells hold huge therapeutic potential both for people and animals. Our research is an important step towards realising that potential for horses and provides an opportunity to validate stem-cell based therapies before clinical studies in humans."
Congratulations to Merial for a creative initiative to celebrate the 25th birthday of Eqvalan®.
The company made a much needed donation towards the upkeep of the Pewsey White Horse in return for being able to use it as part of Eqvalan's birthday celebration publicity programme for 2008.
The money will be used to restore the protective fencing around the ancient landmark, near Marlborough in Wiltshire.
Merial's Claire Parry- Baggott explains: "There are a number of white horse sites across the UK, many of which are extremely popular visitor destinations. To keep these sites open to the public requires year-round maintenance, often from a small army of volunteers.
"Horse owners have been using Eqvalan to help protect their trusty companions for 25 years, and this initiative will help provide protection of a different kind!
"The idea sprang from the current Eqvalan advertising campaign which celebrates 25 years of worming protection. The result is a fantastic 100 feet replica of our Eqvalan birthday horse, and brand new fencing for the Pewsey White Horse!
"We were delighted to help the Pewsey Council raise funds to preserve the site and hopefully this money will enable the horse to be enjoyed by many for years to come," concludes Claire.
Zoetis has announced that Horse & Country TV (Sky Channel 253) will be airing the Vet Essentials episode on worm control in horses from today until 26th March.
The programme, made in association with Zoetis, follows presenter Jenny Rudall on her mission to explore every aspect of worming horses, including how to tackle encysted small redworm. Jenny talks to vet Ben Gaskell from Minster Vets for the low down on worm control, before heading off to the Moredun Research Institute in Scotland to meet parasitology experts Jacqui Matthews and Thomas Tzelos to find out more about the role of faecal worm egg counts, the damage that can be caused by worm burdens and the growing problem of resistance.
Zoetis vet Wendy Talbot said: "The programme should be a big help to vets when it comes to explaining worming to horse owners. They can tell their clients about it and encourage them to watch. It will help educate them about all aspects of worming and specifically about the threat of encysted small redworm at this time of year. This, in turn, should help protect horses against this potentially fatal parasite."
The company is encouraging the profession to help spread the word about the new to clients by email, via Facebook and by word of mouth.
Biomérieux says the new test, which is used on the Biofire Spotfire System, detects seven infectious respiratory pathogens (six viruses and/or a strain of bacteria*), from a nasopharyngeal swab, in under 20 minutes.
The company says the new test’s ability to distinguish between viral and bacterial infections is important for ensuring antibiotics are used appropriately to reduce the risk of resistance.
Biomérieux says VetFire can be used to make informed decisions about when to isolate and treat animals when respiratory infections are suspected, to mitigate the impact of an outbreak in a contained area, such as a yard, by allowing rapid quarantine measures, and perhaps in time as a standard test ahead of animals travelling for competition, to ensure they are fit and healthy.
VetFire is commercially available in United Kingdom, Ireland and France, with possible expansion plans to other countries in the near future.
https://www.biomerieux.com/corp/en/our-offer/clinical-products/vetfire.html
*Equine Herpesvirus type 1, Equine Herpesvirus type 4, Influenza A, Equine Rhinovirus A, Equine Rhinovirus B, Equine Adenovirus 1, Streptococcus equi equi
The increase has prompted a call by Equine Infectious Disease Surveillance (EIDS) for equine professionals and owners to strengthen biosecurity and consider vaccination to help reduce disease spread.
EIDS has been monitoring diagnoses reported to SES and says the data indicates a genuine increase rather than normal year-to-year variation.
With the number of confirmed cases climbing, EIDS and the SES network are urging veterinary professionals and horse owners to revisit their yard management practices, saying that simple but consistent actions, such as isolating new arrivals, disinfecting shared equipment, and post-outbreak screening can make a substantial difference in controlling the disease.
In addition, they recommend the Strangvac vaccine, saying that when combined with good hygiene and daily temperature checking, can help reduce both the risk of infection and onward spread.
Dr Richard Newton of EIDS said, “These findings are a clear reminder that strangles remains an ever-present risk to the UK horse population.
"The increase in diagnoses underlines the importance of continued vigilance, prompt reporting, and proactive prevention measures.”
https://equinesurveillance.org/ses/
Merial has announced that it has joined forces with the Animal Health Trust to hold Equine Flu Awareness Month in April.
Organisers say that the aim is to increase awareness, understanding and virus surveillance of this highly contagious evolving disease.
The AHT’s head of epidemiology and disease surveillance, Dr Richard Newton said: "The creation of Equine Flu Awareness Month is an important step forward for the equine industry. There have been 52 recorded outbreaks of equine influenza in the last two years, and whilst this may sound considerable, we believe it’s actually just the tip of the iceberg."
Equine Flu Awareness Month will integrate the Horserace Betting Levy Board (HBLB) Equine Influenza Surveillance Programme at the AHT with disease outbreak alerts and horse owner education to increase awareness of flu surveillance and vaccination.
The surveillance programme provides ongoing free sampling to all practices registered to the service.
Richard added: "We are fortunate that the HBLB invests in this important scheme which also benefits the industry as a whole. We know that just 40% of the total UK herd is vaccinated, so when you consider that all racehorses and many other competing and performance horses are vaccinated under compulsory rules, that leaves the remainder of the herd even less protected and the total percentage well short of the 70% required in order to prevent an epidemic¹,².
"All isolated viruses in the recent outbreaks are known to be of the Florida Clade 2 sublineage of H3N8 equine influenza, and nearly all outbreaks were in unvaccinated horses or in those whose vaccinations were not up to date³.
"Historical models indicate that an epidemic occurs every 10 to 15 years⁴. The last large outbreak in the UK, which affected vaccinated racehorses, occurred in 2003, so surveillance of virus activity, vaccination and development of vaccines to match the circulating strains are key to preventing another outbreak.
"Many horses that don’t travel are still at risk of equine influenza, but frequently go unvaccinated. These animals are not only at risk of contracting and amplifying virus from their stable-mates that do travel, but are also at risk of airborne infection as equine flu is capable of travelling over a mile as an aerosol on the wind."
Equine Flu Awareness Month will include a focus on practice vaccine amnesties and practice promotional tools with the objective to increase awareness among horse owners, for them to better understand the risks and signs of equine flu.
Louise Radford MRCVS from Merial said: "In addition to the HBLB funded surveillance scheme providing free registration and virus testing, other services include Tell-Tail™ alerts for practices when there is an outbreak in the region, and Tell-Tail™ links to alert clients to outbreaks of equine flu and encourage them to vaccinate."
She added: "Tell-Tail™ Links is a great way to let your clients know when there is an increased risk of equine flu due to an outbreak in the area. When the first broadcast was launched, a text was sent from a practice in Cardiff to 777 horse owners and within 2 weeks, 47 new horses were booked in for a primary vaccination course."
As part of the initiative, Merial is also running a draw to win one of three BEVA vouchers worth up to £1000. To enter, sign up or renew your Tell-Tail™ registration during April 2016 at: www.equinefluawareness.com.
To sign up to the free HBLB Equine Influenza Surveillance Service run by the AHT, visit: www.equiflunet.org.uk
A new US colic study, published in Equine Veterinary Journal (EVJ), in partnership with the American Association of Equine Practitioners, has identified various risk factors, including delayed faecal output and increasing blood lactate, associated with post-anaesthetic colic.
The study Risk factors associated with gastrointestinal dysfunction in horses undergoing elective procedures under general anaesthesia was conducted by surgeons based at the College of Veterinary Medicine and Biomedical Sciences at Colorado State University, USA.
The authors say that the research should enable vets to implement preventative measures to help reduce incidences of colic in the future.
Gastrointestinal pain has been estimated to occur in 2.8-6% of horses following general anaesthesia for elective procedures, the most common cause being impaction of the large intestine or caecum.
The medical records of 416 horses undergoing general anaesthesia were collected over a two-year period and the potential risk factors were examined. 8.7% of horses were diagnosed with gastrointestinal dysfunction - higher than previous estimates probably because the study included horses requiring treatment for decreased faecal output whereas previous studies did not. Potential risk factors were assessed, including faecal output, which was decreased in 38.9% of cases, blood lactate, position during surgery, rectal temperature and breed of horse.
The results showed that Arabian horses, increasing blood lactate, right lateral recumbency, decreased rectal temperature post-procedure and delayed passage of faeces were significantly associated with an increased risk of gastrointestinal dysfunction.
Diana Hassel, who instigated the study, said: "These findings should help the clinician identify higher risk horses and be proactive about their management in the post-anaesthetic period.
"This may include pre-emptive nasogastric intubation and administration of mineral oil and/or water and electrolytes. Although core temperature control in horses is difficult to achieve in adult horses during surgery, further research into this field may prove beneficial."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "This study brings obvious and immediate practical benefits for clinicians and the horses under their care. Rigorous monitoring of higher risk surgical cases should lead to a reduction in incidences of post-operative colic, making recovery procedures less difficult and outcomes more favourable."
The MonitorME project, launched this month, collects antimicrobial usage data from equine practices around the UK, to better understand how antibiotics are used within the sector.
The project is being led by BEVA President Bruce Bladon (pictured) and it will be the main theme at BEVA Congress (10-13 September 2025, ICC Birmingham).
Bruce said: “Growing resistance to antibiotics is a very serious public health crisis, which is why I have chosen it as the overriding theme for my presidential year and for the forthcoming BEVA Congress.
“The World Health Organisation has the usage of veterinary antimicrobials firmly in their sights and the possibility of legislation being implemented to limit our access to these vital drugs is becoming ever more likely.
“It is important that we demonstrate, as a sector, that our usage of antimicrobials is responsible and proportionate, to ensure continued access.
"Taking part in a project like this is, without a doubt, the right thing to do.”
Practices are being asked to submit usage data from their practice management systems (PMS) to the BEVA office, where it will contribute to nationwide reporting of antibiotic use in UK equine practice.
Ideally, they need to record the total mg of each antimicrobial used, together with the number of horses treated last year (in total, not just those treated with antibiotics) and their average weight if available.
The data is analysed and then collated into annual reports, which are published on the BEVA MonitorME webpage.
The 2023 report is now available and will be updated periodically as practices continue to submit their 2023 data.
2024 data collection has started, so equine practices can send their data to antibiotics@beva.org.uk whenever they’re ready.
https://www.beva.org.uk/Resources/Medicines/Antibiotics/MonitorME#aims
https://www.bevacongress.org